SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Evexia Lifecare Ltd (524444)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524444 NSE: Trading | Small Cap | Evexia Lifecare Share Price

₹1.92 0.00 (0.00%)

As on 04-Jun'26 16:59

Evexia Lifecare Ltd (524444)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524444 NSE: Trading | Small Cap | Evexia Lifecare Share Price

₹1.92 0.00 (0.00%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹360 Cr.
Current Price
₹1.9
52-Week Low / High
₹0 / 3
TTM EPS
₹0
TTM Sales
₹85.5 Cr.
Book Value per Share
₹2.2
P/E Ratio
439.03
Higher than its 5-year historical median
Industry PE
36
Price to Book (P/B)
0.89
Lower than its 5-year historical median
Price to Sales (P/S)
4.22
Higher than its 5-year historical median
EV/EBITDA
328.59
Higher than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
0.29%
Underperforms industry median
Return on Capital Employed (ROCE)
0.20%
Underperforms industry median
Return on Assets (ROA)
0.08%
Operating Profit Margin
2.3%
Net Profit Margin
0.87%
Gross Profit Margin
2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
52.81%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
25%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-36.52%
Asset Quality
Promoter Holding
3.36%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹220 Cr.
Equity
₹187.7 Cr.
Face Value
₹1
All Time Low / High
₹0.06 / 17.00

Evexia Lifecare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Evexia Lifecare Ltd a good quality company?
Evexia Lifecare Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Evexia Lifecare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Evexia Lifecare Ltd vs industry peers?
Evexia Lifecare Ltd revenue CAGR is -2.95%, compared to the industry median CAGR of 0%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Evexia Lifecare Ltd?
Promoters hold 3.36% of the Evexia Lifecare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Evexia Lifecare Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 6.1% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Evexia Lifecare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ0.5%1.9%0.9%3.1%6.9%2.4%2.8%0.7%0.3%0.2%-
Value Creation
Index ⓘ		-1.0-0.9-0.9-0.8-0.5-0.8-0.8-1.0-1.0-1.0-

Growth Parameters ⓘ
Sales ⓘ3417867.89297.450.771.668.754.983.985
Sales YoY Gr.-422.8%-61.8%35.7%5.9%-48%41.3%-4.1%-20.1%52.8%-
Adj EPS ⓘ00000.1000000
YoY Gr.-0%0%100%200%-66.7%-50%200%-33.3%-100%-
BVPS (₹) ⓘ1.11.11.11.11.21.21.21.31.42.22.2
Adj Net
Profit ⓘ		0.40.90.51.53.51.30.81.91.10.70
Cash Flow from Ops. ⓘ10.910-13.2-1.3-1.74-4.9-2.5-2.2-5.9-
Debt/CF from Ops. ⓘ0.70.4-0.5-3.7-3.51.7-1.2-274.4-313.5-63.1-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ10.6%-3%5.4%52.8%
Adj EPS ⓘ-100%-100%-100%-100%
BVPSⓘ8.2%13.4%22.7%56.5%
Share Price 7% -31.3% -12.5% -22.9%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		0.61.40.82.14.51.612.21.10.30
Op. Profit
Mgn % ⓘ		0.80.70.3-0.4-6.1-142.63.32.32.82.31.9
Net Profit
Mgn % ⓘ		1.10.50.81.73.62.51.12.820.90
Debt to
Equity ⓘ		0.10.10.10.10.10.10.18.370.9-
Working Cap
Days ⓘ		9123271,1088117971,230609628876614235
Cash Conv.
Cycle ⓘ		-599433666621239-357314198

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales341786892975172695584
Operating Expenses ⓘ + 34176689210312369675382
Manufacturing Costs0010000000
Material Costs331756591964767645080
Employee Cost 0010000110
Other Costs ⓘ 00218752231
Operating Profit ⓘ -01-0-0-6-722222
Operating Profit Margin (%) -0.1%0.7%-0.6%-0.4%-6.1%-142.0%3.3%2.3%2.8%2.3%
Other Income ⓘ + 001311740210
Exceptional Items ⓘ -0000000000
Interest ⓘ 0000000000
Depreciation ⓘ 0000000000
Profit Before Tax ⓘ 0112522321
Tax ⓘ 0001111100
Profit After Tax 0102311211
PAT Margin (%) 0.5%0.5%0.7%1.7%3.6%2.5%1.1%2.9%2.1%0.9%
Adjusted EPS (₹)0.00.00.00.00.10.00.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Evexia Lifecare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 6566737578808091105413
Share Capital ⓘ 626262626262626671188
Reserves ⓘ 3411131618182534225
Debt +6465676695683374
Long Term Debt6454000689683374
Short Term Debt0011676600
Minority Interest0000000000
Trade Payables35351343462922315854
Others Liabilities ⓘ 21141149992231719323
Total Liabilities ⓘ 108219206222223139125836848864

Fixed Assets

Net Fixed Assets ⓘ +2299999111111
Gross Block42911121212151515
Accumulated Depreciation2003333445
CWIP ⓘ 0000002000
Investments ⓘ 2100011699699709
Inventories0111100102
Trade Receivables221393355684512288887
Cash Equivalents 2100001000
Others Assets ⓘ 80751631571458399965055
Total Assets ⓘ 108219206222223139125836848864

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 1110-13-1-24-5-3-2-6
PBT ⓘ 0112522321
Adjustment ⓘ -0-0-0-2-321-111
Changes in Working Capital ⓘ 119-13-1-40-5-4-4-7
Tax Paid ⓘ 000-01-1-2-1-1-1
Cash Flow From Investing Activity ⓘ + 22-502-56-6972-15
Capex -0-0-7-0-1-0-2-0-00
Net Investments 2210000000
Others ⓘ 00003-58-6972-15
Cash Flow From Financing Activity ⓘ + -12-12181-01-0699020
Net Proceeds from Shares ⓘ -0070000000
Net Proceeds from Borrowing ⓘ 342000069701
Interest Paid ⓘ -0-0-0-0-0-0-0-0-0-0
Dividend Paid ⓘ 0000000000
Others ⓘ -15-16101-01-02-019
Net Cash Flow ⓘ 10-10-001-10-0

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.251.370.682.325.021.751.112.541.270.29
ROCE (%)0.451.90.943.16.852.392.770.710.260.2
Asset Turnover Ratio0.371.090.320.430.440.280.540.140.070.1
PAT to CFO Conversion(x)N/A10N/A-0.5-0.674-5-1.5-2-6
Working Capital Days
Receivable Days127.50165.90465174.80230408.60145.90107.10388.10382.30
Inventory Days3.401.303.502.102.102.301.1045.305.50
Payable Days192.6073.10134.60112170.90290.40139.90151.90324.40256.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *15.3515.3515.350.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Evexia Lifecare Ltd FAQs

The current trading price of Evexia Lifecare on 04-Jun-2026 16:59 is ₹1.92.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Evexia Lifecare stood at ₹360.4 Cr

The latest P/E ratio of Evexia Lifecare as of 03-Jun-2026 is 439.0.

The latest P/B ratio of Evexia Lifecare as of 03-Jun-2026 is 0.89.

The 52-week high of Evexia Lifecare is ₹2.69 and the 52-week low is ₹0.47.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Evexia Lifecare is ₹85.46 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Evexia Lifecare Ltd is a below average quality company.

The key valuation ratios of Evexia Lifecare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Evexia Lifecare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Evexia Lifecare Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×